Ειδήσεις: PHARMACEUTICALS | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

25/03 03:16 bloomberg.com

Merck Nears Deal to Buy Terns Pharmaceuticals

Merck Terns Pharmaceuticals acquisition biotech U.S. market drug pipeline

24/03 20:42 defenseworld.net

Insmed (NASDAQ:INSM) Price Target Cut to $175.00 by Analysts at Wells Fargo & Company

Insmed price target Wells Fargo Royal Bank of Canada Rothschild Weiss Ratings

24/03 19:13 defenseworld.net

Assenagon Asset Management S.A. Has $377.58 Million Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX

Vertex Pharmaceuticals Assenagon Asset Management Q4 holdings institutional investor pharmaceutical stocks SEC filing

24/03 18:35 defenseworld.net

Mirum Pharmaceuticals (NASDAQ:MIRM) Receives Buy Rating from HC Wainwright

Mirum Pharmaceuticals buy rating price objective HC Wainwright Evercore Cantor Fitzgerald

24/03 15:10 yahoo.com

NRx Pharmaceuticals Q4 Earnings Call Highlights

NRx Pharmaceuticals Q4 earnings revenue EPS guidance drug pipeline

24/03 13:27 yahoo.com

Truist Raises Vertex (VRTX) Price Target Following Phase 3 Trial Results

Vertex Pharmaceuticals Truist Securities price target Phase 3 trial biotech drug approval

24/03 11:05 yahoo.com

NRx Pharmaceuticals Wraps Virtual Annual Meeting, Eyes Pivotal 2025 Earnings Call Ahead

NRx Pharmaceuticals virtual annual meeting 2025 earnings call biotech pipeline investor relations financial outlook

23/03 16:30 investing.com

Tarsus Pharmaceuticals shares rise on China drug approval milestone

Tarsus Pharmaceuticals China drug approval stock surge biotech regulatory milestone market reaction

23/03 11:49 defenseworld.net

Nordea Investment Management AB Has $202.61 Million Position in Vertex Pharmaceuticals Incorporated $VRTX

Nordea Investment Management Vertex Pharmaceuticals hedge fund shareholding institutional investor pharmaceutical

23/03 11:49 defenseworld.net

Nordea Investment Management AB Has $202.61 Million Position in Vertex Pharmaceuticals Incorporated $VRTX

Nordea Investment Management Vertex Pharmaceuticals hedge fund shareholding institutional investor pharmaceutical

Loading...